Repligen (RGEN) Net Shares Issued and Repurchased (2012 - 2026)
Repligen's (RGEN) quarterly Net Shares Issued and Repurchased came in at $39110.0 in Q1 2026, up 40.42% year-over-year from $27852.0 in Q1 2025, and down 27.56% quarter-over-quarter from $53987.0 in Q4 2025.
Analysis
Repligen (RGEN) Net Shares Issued and Repurchased (2012 - 2026) Analysis & Trends
Repligen (RGEN) has reported Net Shares Issued and Repurchased for 13 consecutive years, with $39110.0 the latest figure, recorded in Q1 2026.
- On a quarterly basis, Net Shares Issued and Repurchased rose 40.42% year-over-year to $39110.0 in Q1 2026; TTM through Mar 2026 was $39110.0, a 40.42% increase from a year earlier, with the FY2025 full-year figure at $53987.0, down 38.51% from the prior year.
- Net Shares Issued and Repurchased was $39110.0 for Q1 2026 at Repligen, down from $53987.0 in the prior quarter.
- Over five years, Net Shares Issued and Repurchased peaked at $87798.0 in Q4 2024 and troughed at $8469.0 in Q1 2022.
- A 5-year average of $43871.8 and a median of $39110.0 in 2026 frame the typical range for Net Shares Issued and Repurchased.
- Across the five-year window, Net Shares Issued and Repurchased soared 154.21% in 2023 and plunged 38.51% in 2025, its largest moves.
- Over 5 years, Net Shares Issued and Repurchased stood at $61753.0 in 2022, then climbed by 18.83% to $73380.0 in 2023, then climbed by 19.65% to $87798.0 in 2024, then slumped by 38.51% to $53987.0 in 2025, then dropped by 27.56% to $39110.0 in 2026.
- The last three Net Shares Issued and Repurchased figures came in at $39110.0 (Q1 2026), $53987.0 (Q4 2025), and $27852.0 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 225.48 Bn | 221.41 Bn | 8.34 Bn | - |
| 2 | Danaher | 144.42 Bn | 140.08 Bn | 3.61 Bn | - |
| 3 | Agilent Technologies | 40.86 Bn | 39.11 Bn | 1.04 Bn | - |
| 4 | Illumina | 30.97 Bn | 29.80 Bn | 770.00 Mn | - |
| 5 | Revvity | 13.85 Bn | 12.83 Bn | 416.87 Mn | - |
| 6 | Bio-Techne | 11.27 Bn | 11.01 Bn | 211.39 Mn | 988,000.00 |
| 7 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.33 Bn | 8.31 Bn | 110.04 Mn | - |
| 9 | 10x Genomics | 8.77 Bn | 8.21 Bn | 112.50 Mn | - |
| 10 | Bruker | 8.30 Bn | 8.09 Bn | 416.00 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 39,110.00 |
| Dec 31, 2025 | 53,987.00 |
| Mar 31, 2025 | 27,852.00 |
| Dec 31, 2024 | 87,798.00 |
| Mar 31, 2024 | 20,968.00 |
| Dec 31, 2023 | 73,380.00 |
| Mar 31, 2023 | 21,529.00 |
| Dec 31, 2022 | 61,753.00 |
| Mar 31, 2022 | 8,469.00 |
| Dec 31, 2021 | 34,114.00 |
| Mar 31, 2018 | 9,588.00 |
| Dec 31, 2017 | 34,157.00 |
| Mar 31, 2017 | 25,157.00 |
| Dec 31, 2016 | 88,592.00 |
| Mar 31, 2016 | 58,900.00 |
| Dec 31, 2015 | 117,346.00 |
| Mar 31, 2015 | 35,600.00 |
| Dec 31, 2014 | 105,831.00 |
| Mar 31, 2014 | 2,400.00 |
| Dec 31, 2013 | 343,500.00 |